re: sirtex quite undervalued The results are from OCT-Dec. This is after the full impact of teaching about 100 more oncologists the procedure and after the previous strong results. Yjen next years results will add the 24 Australian Hospitals that are now getting reimbursed along with Sirtex for the procedue. Considering that 61 US centers were reimbursed this coming quarter copared to only 35 a year ago the growth prospects are outstanding, and the sp is way behind the news.
sirtex, resmed, csl and cochlear, page-19
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.40M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $61.98K | 351.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 11238850 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1266857 | 36 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |